据报强生支付逾1亿美元结束过千宗婴儿爽身粉致癌诉讼
《彭博》引述消息人士报道,强生(Johnson & Johnson )(JNJ.US)将支付超过1亿美元,结束1,000多个有关婴儿爽身粉致癌的诉讼。
强生正面对逾1.9万宗婴儿爽身粉致癌诉讼,不过强生一直声称婴儿爽身粉中所使用的滑石粉是安全的,不含石棉,亦不会引致癌症。
强生在5月时表示,由於在一系列法律诉讼,以及连串不实安全讯息导致婴儿爽身粉需求下降,已停止在美国及加拿大销售婴儿爽身粉。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.